Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
QuintilesIMS
Fuji
Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Harvard Business School
Citi

Generated: June 22, 2018

DrugPatentWatch Database Preview

VENTAIRE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Ventaire patents expire, and what generic alternatives are available?

Ventaire is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in VENTAIRE is protokylol hydrochloride. Additional details are available on the protokylol hydrochloride profile page.
Summary for VENTAIRE
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 10
Patent Applications: 40
DailyMed Link:VENTAIRE at DailyMed
Drug patent expirations by year for VENTAIRE
Synonyms for VENTAIRE
1, 4-[2-[[2-(1,3-benzodioxol-5-yl)-1-methylethyl]amino]-1-hydroxyethyl]-, hydrochloride
1,2-Benzenediol, 4-(2-((2-(1,3-benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-, HCl
1,2-Benzenediol, 4-(2-((2-(1,3-benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-((2-(1,3-benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-, hydrochloride (9CI)
1,2-benzenediol, 4-(2-((2-(1,3-benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-, hydrochloride(9ci)
136-69-6
136-70-9 (Parent)
4-(2-((2-(1,3-Benzodioxol-5-yl)-1-methylethyl)amino)-1-hydroxyethyl)-1,2-benzenediol HCl
4-(2-{[2-(1,3-benzodioxol-5-yl)-1-methylethyl]amino}-1-hydroxyethyl)-1,2-benzenediol hydrochloride
4-[2-[1-(1,3-benzodioxol-5-yl)propan-2-ylamino]-1-hydroxyethyl]benzene-1,2-diol hydrochloride
7U7O8Q48IO
AC1L1RJ7
AC1Q3EVB
alpha-(((alpha-Methyl-3,4-methylenedioxyphenethyl)amino)methyl)protocatechuyl alcohol, hydrochloride
Asmetil
Atma-sanol
Benzyl alcohol, 3,4-dihydroxy-alpha-(((alpha-methyl-3,4-(methylenedioxy)phenethyl)amino)methyl)-, hydrochloride
Benzyl alcohol,4-dihydroxy-.alpha.-[[[.alpha.-methyl-3,4-(methylenedioxy)phenethyl]amino]methyl]-, hydrochloride
Beres
Biturix
C18H21NO5.HCl
Caytine hydrochloride
CHEMBL1200893
D02FCQ
EINECS 205-254-8
FT-0674124
LS-42888
NSC 113490
NSC-113490
NSC113490
Palison
Protoklol hydrochloride
Protokylol HCl
Protokylol hydrochloride
Protokylolhydrochlorid
SCHEMBL210099
UNII-7U7O8Q48IO
WLN: T56 BO DO CHJ G1Y1 & M1YQR CQ DQ & GH

US Patents and Regulatory Information for VENTAIRE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us VENTAIRE protokylol hydrochloride TABLET;ORAL 083459-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Deloitte
Cerilliant
Fish and Richardson
UBS
Julphar
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.